Skip to main content

Nosocomial pneumonia and bacteremia in intensive care: results from the Belgian national surveillance, 1996-1998

In 1996 the Scientific Institute of Public Health — Louis Pasteur (IPH), in collaboration with the Belgian Society of Intensive Medicine and Emergency Medicine, started a multicentre surveillance of intensive care units (ICU) acquired pneumonias and bacteremia. From January 1996 to June 1998, 60% of Belgian acutecare hospitals (n = 101) participated during at least one surveillance period (3 months), and 64% of those participated more than one period. A total of 31 374 patients were included for the analysis.

In 4.7% (95% CI 4.5—5.0) of the patients a pneumonia with onset later than 48 h of ICU stay and matching CDC criteria for nosocomial pneumonia was registered. In 89% of those at least one ventilation-day had preceded the onset of the infection (RR 10.4%; 8.9—12.2). The number of ventilator-associated pneumonias per 1000 ventilation-days was 19.0/1000 ventilation-days, varying from 11.9 in coronary surgery patients to more than 25 in patients having undergone neurosurgery, non-cardiac thoracic surgery, vascular surgery and transplantation. The predominant micro-organisms were Pseudomonas aeruginosa (recovered in 18.0% of the episodes), Staphylococcus aureus (17.7%), Escherichia coli (12.6%), Candida spp. (12.1%) and Enterobacter spp. (9.5%).

Bacteremia was reported in 2.4% of the patients. Five percent of bacteremia occurred within the first 48 h. Forty percent (n = 301) were secondary to another infection site and 55% (1.3% of the patients and 2.3 BSIs per 1000 patient-days) matched the CDC case definition of laboratory-confirmed primary bacteremia. The device-adjusted primary bacteremia rate was 3.1/1000 catheter-days and varied between 1.5 in coronary surgery to 4.8 in patients with multiple trauma and 6.0 in neurosurgical patients. The five predominant micro-organisms in primary bacteremia were Staphylococus epidermidis (in 33.3% of the episodes), Staphylococcus aureus (12.8%), Enterococcus faecalis (7.1%), Pseudomonas aeruginosa (6.1 %) and Enterobacter aerogenes (5.7%).

The frequent participation to the national surveillance led to an important national database that allows to study the risk factors of ICU-acquired infections, to identify areas for prevention and to improve the inter-ICU comparability of infection rates according to the risk profile of the different ICU populations. International comparisons remain a delicate matter by lack of internationally standardised surveillance methods.

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Suetens, C., Jans, B., Carsauw, H. et al. Nosocomial pneumonia and bacteremia in intensive care: results from the Belgian national surveillance, 1996-1998. Crit Care 3, P055 (2000). https://doi.org/10.1186/cc430

Download citation

Keywords

  • Intensive Care Unit Stay
  • Enterococcus Faecalis
  • Nosocomial Pneumonia
  • National Surveillance
  • Enterobacter Aerogenes